All In MedTech

Device Trial Radar · NCT05499624

POMCO2 Clinical Study MicroTrend System pCO2 Sensor

Safety & Efficacy of Oral Mucosal Carbon Dioxide Pressure (POMCO2) Measurement to Monitor Tissue Perfusion

Last checked: Nov 20, 2026Latest source record: Mar 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

7

Actual

Start

Nov 22, 2022

Primary completion

Jan 9, 2023

Study completion Jan 9, 2023

Sponsor

Lead sponsor
ExoStat Medical, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Bright Research Partners
First posted
Aug 12, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Basic science
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this non-significant risk (NSR) study is to evaluate the safety and efficacy of the MicroTrend System by correlating POMCO2 data with relevant clinical metrics including arterial pressure and heart rate.

Conditions

  • Hypoperfusion

Interventions

  • MicroTrend SystemDevice

    The hands-free device measures oral mucosal carbon dioxide pressure (POMCO2) and functions outside of the body and does not require a surgical procedure or any significant deviation from standard practice to operate.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Correlation between POMCO2Time frame: 4-6 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Captain James A. Lovell Federal Health Care Center

    North Chicago, Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.